SLIDESHOW: Best Dividend Paying Stocks Analysts Like in the Dow
By Dividend Channel Staff, updated Tue, March 19, 2:21 AM
This Slide: #1 of 10 |
#10. Amgen Inc (NASDAQ:AMGN) — Ranked #21 in the DJIA by Analysts, 3.35% Dividend Yield
Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).
|
Open the Dividend Channel AMGN Page (in a new window) »
AMGN Next Dividend Date » (Projection based upon history) AMGN Dividend Growth Rate » Quotes delayed 20 minutes |
Buy (2.83 out of 4) 26th percentile
(ranked lower than approx. 74% of all stocks covered)
Analysts' Target Price: AMGN Forecast Based on data provided by Zacks Investment Research via Quandl.com |
|